针对针对性降解SARS-CoV-2 Spike-1的Aptamer-Hytac奇默体

Carme Fàbrega1,2, Núria Gallisà-Suñé3, Alice Zuin3

  • 1Department of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona 18, 08034 Barcelona, Spain.

Cells
|November 8, 2024
PubMed
概括

开发了针对SARS-CoV-2尖端蛋白的基于aptamer的新型分子. 这些分子触发蛋白质降解,提供了对抗冠状病毒进展的有希望的策略.